BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11032923)

  • 1. Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin.
    Hirai K; Ishiko O; Sumi T; Kanaoka Y; Ogita S
    Oncol Rep; 2000; 7(6):1243-5. PubMed ID: 11032923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic analysis of cisplatin and its metabolites in cancer patients: possible misinterpretation of covariates for pharmacokinetic parameters calculated from the concentrations of unchanged cisplatin, ultrafiltered platinum and total platinum.
    Hanada K; Nishijima K; Ogata H; Atagi S; Kawahara M
    Jpn J Clin Oncol; 2001 May; 31(5):179-84. PubMed ID: 11450990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on changes in plasma platinum concentrations after administration of CDDP to maintenance hemodialysis patients].
    Suwata J; Hiraga S; Hida M; Takamiya T; Iida T; Sato T
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):243-8. PubMed ID: 3341786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a prediction model of cisplatin dose based on total platinum plasma concentration.
    Desoize B; Berthiot G; Manot L; Coninx P; Dumont P
    Eur J Cancer; 1996 Sep; 32A(10):1734-8. PubMed ID: 8983282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.
    Kigawa J; Minagawa Y; Itamochi H; Kanamori Y; Ishihara H; Terakawa N
    Obstet Gynecol; 1995 Aug; 86(2):265-8. PubMed ID: 7617358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin.
    Vermorken JB; van der Vijgh WJ; Klein I; Gall HE; van Groeningen CJ; Hart GA; Pinedo HM
    Clin Pharmacol Ther; 1986 Feb; 39(2):136-44. PubMed ID: 3943271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma platinum elimination in a hemodialysis patient treated with cisplatin.
    Gorodetsky R; Vexler A; Bar-Khaim Y; Biran H
    Ther Drug Monit; 1995 Apr; 17(2):203-6. PubMed ID: 7624912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
    Eiseman JL; Beumer JH; Rigatti LH; Strychor S; Meyers K; Dienel S; Horn CC
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):143-52. PubMed ID: 25398697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
    Hamana S; Motoyama S; Takeuchi S; Ku Y; Yoshida S; Miyahara Y; Tateiwa Y; Maruo T
    Am J Clin Oncol; 2001 Jun; 24(3):241-6. PubMed ID: 11404493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
    Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
    Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients.
    Erdlenbruch B; Nier M; Kern W; Hiddemann W; Pekrun A; Lakomek M
    Eur J Clin Pharmacol; 2001 Aug; 57(5):393-402. PubMed ID: 11599657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimens.
    Gandara DR; Perez EA; Denham A; Wiebe VJ; DeGregorio MW
    Cancer Chemother Pharmacol; 1989; 24(2):135-6. PubMed ID: 2786459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans.
    Fournier C; Vennin P; Hecquet B
    Cancer Chemother Pharmacol; 1988; 21(1):75-7. PubMed ID: 3342469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
    Li S; Huang H; Liao H; Zhan J; Guo Y; Zou BY; Jiang WQ; Guan ZZ; Yang XQ
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):96-105. PubMed ID: 23127487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of cisplatin and vindesine in a patient with chronic renal failure undergoing hemodialysis].
    Ayabe H; Uchikawa T; Kimino K; Tagawa Y; Kawahara K; Tomita M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3283-5. PubMed ID: 2782920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Superselective intra-arterial infusion chemotherapy of high-dose cisplatin for advanced paranasal sinus carcinomas].
    Yokoyama J; Shiga K; Saijo S; Matumoto K; Ogawa Y
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):967-73. PubMed ID: 10396325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum pharmacokinetics in sulphur-crested cockatoos (Cacatua galerita) following single-dose cisplatin infusion.
    Filippich LJ; Bucher AM; Charles BG
    Aust Vet J; 2000 Jun; 78(6):406-11. PubMed ID: 10920780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.